Cytokinetics Inc (CYTK)
Quick ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 94,857 | 46,888 | 190,517 | 120,351 | 113,399 | 99,692 | 68,639 | 101,616 | 65,582 | 106,238 | 93,631 | 115,422 | 112,666 | 90,562 | 37,154 | 44,594 | 82,985 | 200,812 | 61,134 | 49,776 |
| Short-term investments | US$ in thousands | 981,157 | 964,804 | 866,633 | 498,985 | 501,800 | 439,547 | 497,083 | 562,346 | 716,995 | 761,426 | 492,395 | 493,552 | 358,972 | 387,074 | 313,147 | 380,983 | 381,075 | 209,452 | 151,929 | 170,930 |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 179,674 | 109,812 | 102,777 | 88,855 | 102,678 | 77,723 | 65,617 | 75,220 | 84,617 | 76,496 | 66,843 | 66,847 | 71,860 | 80,868 | 61,766 | 35,930 | 31,199 | 27,573 | 22,696 | 20,741 |
| Quick ratio | 5.99 | 9.21 | 10.29 | 6.97 | 5.99 | 6.94 | 8.62 | 8.83 | 9.25 | 11.34 | 8.77 | 9.11 | 6.56 | 5.91 | 5.67 | 11.84 | 14.87 | 14.88 | 9.39 | 10.64 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($94,857K
+ $981,157K
+ $—K)
÷ $179,674K
= 5.99
The quick ratio of Cytokinetics Inc, a measure of its ability to meet short-term obligations with its most liquid assets, has shown fluctuations over the reported periods. Beginning at a robust 10.64 on March 31, 2020, the ratio remained relatively high, indicating a healthy liquidity position. However, there was a significant decrease by June 30, 2021, with the quick ratio dropping to 5.67, suggesting a potential strain on the company's ability to meet short-term obligations.
Subsequent fluctuations were observed with the ratio experiencing a slight recovery, reaching 11.34 on September 30, 2022, before declining again to 5.99 by December 31, 2023. Notably, the quick ratio increased to 10.29 on June 30, 2024, signifying an improvement in the company's short-term liquidity position. However, by the end of December 31, 2024, the ratio fell back to 5.99.
Overall, the quick ratio of Cytokinetics Inc has displayed variability, indicating potential shifts in the company's ability to cover its short-term liabilities with its most liquid assets. This underscores the importance of closely monitoring liquidity levels to ensure financial stability and meet obligations on time.
Peer comparison
Dec 31, 2024